The National Comprehensive Cancer Network Updates Its 2026 NCCN Clinical Practice Guidelines In Oncology For Bladder Cancer To Include Immunitybio's Anktiva In Combination With Bacillus Calmette-guérin (BCG) For BCG-Unresponsive Non-Muscle Invasive Bladder Cancer With Papillary-Only Disease